References
Key articles
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
Galvin JE, Sadowsky CH. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012 May-Jun;25(3):367-82.Full text Abstract
National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. Jun 2018 [internet publication].Full text
American College of Radiology. ACR appropriateness criteria: dementia. 2024 [internet publication].Full text
Reference articles
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
2. Prince M, Wimo A, Guerchet M, et al. Alzheimer's Disease International. World Alzheimer Report 2015. Aug 2015 [internet publication].Full text
3. GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Jan;18(1):88-106.Full text Abstract
4. Alzheimer's Disease International. Numbers of people with dementia worldwide: an update to the estimates in the World Alzheimer Report 2015. Nov 2020 [internet publication].Full text
5. GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022 Feb;7(2):e105-25.Full text Abstract
6. World Health Organization. Global status report on the public health response to dementia. Sep 2021 [internet publication].Full text
7. Kramarow EA. Diagnosed dementia in adults age 65 and older: United States, 2022. Natl Health Stat Report. 2024 Jun;(203):1-9.Full text Abstract
8. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020 Aug 8;396(10248):413-46.Full text
9. Manly JJ, Jones RN, Langa KM, et al. Estimating the prevalence of dementia and mild cognitive impairment in the US: the 2016 health and retirement study harmonized cognitive assessment protocol project. JAMA Neurol. 2022 Dec 1;79(12):1242-9.Full text Abstract
10. Goodman RA, Lochner KA, Thambisetty M, et al. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013. Alzheimers Dement. 2017 Jan;13(1):28-37.Full text Abstract
11. Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med. 1988 Sep 15;109(6):476-86. Abstract
12. Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med. 2003 Oct 13;163(18):2219-29. Abstract
13. Lee Y, Back JH, Kim J, et al. Systematic review of health behavioral risks and cognitive health in older adults. Int Psychogeriatr. 2010 Mar;22(2):174-87. Abstract
14. Ruan Y, Tang J, Guo X, et al. Dietary fat intake and risk of Alzheimer's disease and dementia: a meta-analysis of cohort studies. Curr Alzheimer Res. 2018;15(9):869-76. Abstract
15. Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024 Aug 10;404(10452):572-628.
16. Sabia S, Fayosse A, Dumurgier J, et al. Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study. BMJ. 2018 Aug 1;362:k2927.Full text Abstract
17. Barnes DE, Byers AL, Gardner RC, et al. Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military veterans. JAMA Neurol. 2018 Sep 1;75(9):1055-61.Full text Abstract
18. Loughrey DG, Kelly ME, Kelley GA, et al. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):115-26.Full text Abstract
19. Cantuaria ML, Pedersen ER, Waldorff FB, et al. Hearing loss, hearing aid use, and risk of dementia in older adults. JAMA Otolaryngol Head Neck Surg. 2024 Feb 1;150(2):157-64.Full text Abstract
20. Anstey KJ, Ashby-Mitchell K, Peters R. Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis. J Alzheimers Dis. 2017;56(1):215-28.Full text Abstract
21. Hussain SM, Robb C, Tonkin AM, et al. Association of plasma high-density lipoprotein cholesterol level with risk of incident dementia: a cohort study of healthy older adults. Lancet Reg Health West Pac. 2024 Feb;43:100963.Full text Abstract
22. Galvin JE, Sadowsky CH. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012 May-Jun;25(3):367-82.Full text Abstract
23. National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. Jun 2018 [internet publication].Full text
24. Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2018 Jan 16;90(3):126-35.Full text Abstract
25. Petersen RC. Mild Cognitive Impairment. Continuum (Minneap Minn). 2016 Apr;22(2 dementia):404-18.Full text Abstract
26. Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr. 2008 Jan;13(1):45-53. Abstract
27. Thal LJ, Grundman M, Klauber MR. Dementia: characteristics of a referral population and factors associated with progression. Neurology. 1988 Jul;38(7):1083-90. Abstract
28. Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019 Jun 1;142(6):1503-1527.Full text Abstract
29. Rizzi L, Rosset I, Roriz-Cruz M. Global epidemiology of dementia: Alzheimer's and vascular types. Biomed Res Int. 2014;2014:908915.Full text Abstract
30. Corey-Bloom J, Thal LJ, Galasko D, et al. Diagnosis and evaluation of dementia. Neurology. 1995 Feb;45(2):211-8. Abstract
31. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies; report of the NINDS-AIREN International Workshop. Neurology. 1993 Feb;43(2):250-60. Abstract
32. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009 Nov;8(11):1006-18. Abstract
33. Okura T, Plassman BL, Steffens DC, et al. Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study. J Am Geriatr Soc. 2011 Mar;59(3):473-81.Full text Abstract
34. Bowen J, Teri L, Kukull W, et al. Progression to dementia in patients with isolated memory loss. Lancet. 1997;349:763-5. Abstract
35. Woolley JD, Khan BK, Murthy NK, et al. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011 Feb;72(2):126-33.Full text Abstract
36. Jellinger KA. Head injury and dementia. Curr Opin Neurol. 2004 Dec;17(6):719-23. Abstract
37. Nordström A, Nordström P. Traumatic brain injury and the risk of dementia diagnosis: a nationwide cohort study. PLoS Med. 2018 Jan 30;15(1):e1002496.Full text Abstract
38. Roberts GW, Gentleman SM, Lynch A, et al. Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):419-25.Full text Abstract
39. Takahata K, Kimura Y, Sahara N, et al. PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury. Brain. 2019 Oct 1;142(10):3265-79.Full text Abstract
41. Spero M, Lazibat I. Creutzfeldt-Jakob disease: case report and review of the literature. Acta Clin Croat. 2010 Jun;49(2):181-7. Abstract
42. Fox C, Smith T, Maidment I, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014 Sep;43(5):604-15.Full text Abstract
43. Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018 Apr 25;361:k1315.Full text Abstract
44. Coupland CAC, Hill T, Dening T, et al. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. 2019 Jun 24;:.Full text Abstract
45. Torres-Bondia F, Dakterzada F, Galván L, et al. Benzodiazepine and Z-drug use and the risk of developing dementia. Int J Neuropsychopharmacol. 2022 Apr 19;25(4):261-8.Full text Abstract
46. Ferreira P, Ferreira AR, Barreto B, et al. Is there a link between the use of benzodiazepines and related drugs and dementia? A systematic review of reviews. Eur Geriatr Med. 2022 Feb;13(1):19-32. Abstract
47. AlDawsari A, Bushell TJ, Abutheraa N, et al. Use of sedative-hypnotic medications and risk of dementia: a systematic review and meta-analysis. Br J Clin Pharmacol. 2022 Feb;88(4):1567-89.Full text Abstract
48. Brieler JA, Salas J, Amick ME, et al. Anxiety disorders, benzodiazepine prescription, and incident dementia. J Am Geriatr Soc. 2023 Nov;71(11):3376-89. Abstract
49. Jayadevappa R, Chhatre S, Malkowicz SB, et al. Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer. JAMA Netw Open. 2019 Jul 3;2(7):e196562.Full text Abstract
50. Pourhadi N, Mørch LS, Holm EA, et al. Dementia in women using estrogen-only therapy. JAMA. 2024 Jan 9;331(2):160-2.Full text
51. Bakulski KM, Seo YA, Hickman RC, et al. Heavy metals exposure and Alzheimer's disease and related dementias. J Alzheimers Dis. 2020;76(4):1215-42.Full text Abstract
52. Burns A, Gallagley A, Byrne J. Delirium. J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):362-7. Abstract
53. National Institute for Health and Care Excellence. Delirium: prevention, diagnosis and management. Jan 2023 [internet publication].Full text
54. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014 Mar 8;383(9920):911-22.Full text Abstract
55. Wilson JE, Mart MF, Cunningham C, et al. Delirium. Nat Rev Dis Primers. 2020 Nov 12;6(1):90.Full text Abstract
56. Han JH, Wilson A, Graves AJ, et al. Validation of the confusion assessment method for the intensive care unit in older emergency department patients. Acad Emerg Med. 2014 Feb;21(2):180-7.Full text Abstract
57. Gusmao-Flores D, Salluh JI, Chalhub RÁ, et al. The confusion assessment method for the intensive care unit (CAM-ICU) and intensive care delirium screening checklist (ICDSC) for the diagnosis of delirium: a systematic review and meta-analysis of clinical studies. Crit Care. 2012 Jul 3;16(4):R115.Full text Abstract
58. Attupurath R, Menon RC, Nair SV, et al. Late-life depression. Ann Long Term Care Clin Care Aging. 2008;16(suppl):21-9.Full text
59. Ralph SJ, Espinet AJ. Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care. J Alzheimers Dis Rep. 2018 Feb 2;2(1):1-26.Full text Abstract
60. Reus VI, Fochtmann LJ, Eyler AE, et al. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia. Am J Psychiatry. 2016 May 1;173(5):543-6.Full text Abstract
61. Yunusa I, Alsumali A, Garba AE, et al. Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis. JAMA Netw Open. 2019 Mar 1;2(3):e190828.Full text Abstract
62. APA Work Group on Alzheimer's Disease and other Dementias, Rabins PV, Blacker D, Rovner BW, et al. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias, second edition. Am J Psychiatry. 2007 Dec;164(12 Suppl):5-56. Abstract
63. Hort J, O'Brien JT, Gainotti G, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol. 2010 Oct;17(10):1236-48.Full text Abstract
64. Scottish Intercollegiate Guidelines Network. Assessment, diagnosis, care and support for people with dementia and their carers. Nov 2023 [internet publication].Full text
65. Fleming KC, Adams AC, Petersen RC. Dementia: diagnosis and evaluation. Mayo Clin Proc. 1995 Nov;70(11):1093-107. Abstract
66. Rodakowski J, Skidmore ER, Reynolds CF 3rd, et al. Can performance on daily activities discriminate between older adults with normal cognitive function and those with mild cognitive impairment? J Am Geriatr Soc. 2014 Jul;62(7):1347-52.Full text Abstract
67. Abell JG, Kivimäki M, Dugravot A, et al. Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension. Eur Heart J. 2018 Sep 1;39(33):3119-3125.Full text Abstract
68. Koch M, Fitzpatrick AL, Rapp SR, et al. Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment. JAMA Netw Open. 2019 Sep 4;2(9):e1910319.Full text Abstract
69. Klingelhofer LR. Delirium, psychosis and dementia in patients with Parkinson's disease. Aktuelle Neurologie. 2011;38:303-08.
70. Petersen RC, Mokri B, Laws ER Jr. Surgical treatment of idiopathic hydrocephalus in elderly patients. Neurology. 1985 Mar;35(3):307-11. Abstract
71. Graff-Radford NR, Godersky JC, Jones MP. Variables predicting surgical outcome in symptomatic hydrocephalus in the elderly. Neurology. 1989 Dec;39(12):1601-4. Abstract
72. Mulrow CD, Feussner JR, Williams BC, et al. The value of clinical findings in the detection of normal pressure hydrocephalus. J Gerontol. 1987 May;42(3):277-9. Abstract
73. Siu AL. Screening for dementia and investigating its causes. Ann Intern Med. 1991 Jul 15;115(2):122-32. Abstract
74. U.S. Preventive Services Task Force. Cognitive impairment in older adults: screening. Feb 2020 [internet publication].Full text
75. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. Abstract
76. Tsoi KK, Chan JY, Hirai HW, et al. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med. 2015 Sep;175(9):1450-8. Abstract
77. Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. Psychiatr Res. 2009 Jan;43(4):411-31. Abstract
78. Peters R, Pinto EM. Predictive value of the Clock Drawing Test. A review of the literature. Dement Geriatr Cogn Disord. 2008;26(4):351-5. Abstract
79. Castilla-Rilo J, López-Arrieta J, Bermejo-Pareja F, et al. Instrumental activities of daily living in the screening of dementia in population studies: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2007 Sep;22(9):829-36. Abstract
80. Holsinger T, Deveau J, Boustani M, et al. Does this patient have dementia? JAMA. 2007 Jun 6;297(21):2391-404. Abstract
81. Wolfs CA, Dirksen CD, Kessels A, et al. Economic evaluation of an integrated diagnostic approach for psychogeriatric patients: results of a randomized controlled trial. Arch Gen Psychiatry. 2009 Mar;66(3):313-23. Abstract
82. Jongstra S, van Gool WA, Moll van Charante EP, et al. Improving Prediction of Dementia in Primary Care. Ann Fam Med. 2018 May;16(3):206-210.Full text Abstract
83. Appels BA, Scherder E. The diagnostic accuracy of dementia-screening instruments with an administration time of 10 to 45 minutes for use in secondary care: a systematic review. Am J Alzheimers Dis Other Demen. 2010 Jun;25(4):301-16. Abstract
84. Seitz DP, Chan CC, Newton HT, et al. Mini-Cog for the detection of dementia within a primary care setting. Cochrane Database Syst Rev. 2021 Jul 14;7(7):CD011415.Full text Abstract
85. Chan CC, Fage BA, Burton JK, et al. Mini-Cog for the detection of dementia within a secondary care setting. Cochrane Database Syst Rev. 2021 Jul 14;7(7):CD011414.Full text Abstract
86. Teng E, Becker BW, Woo E, et al. Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Dis Assoc Disord. 2010 Oct-Dec;24(4):348-53.Full text Abstract
87. Merello M, Sabe L, Teson A, et al. Extrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1503-9.Full text Abstract
88. Huff FJ, Belle SH, Shim YK, et al. Prevalence and prognostic value of neurologic abnormalities in Alzheimer's disease. Dementia. 1990;1:32-40.
89. Gates GA, Karzon RK, Garcia P, et al. Auditory dysfunction in aging and senile dementia of the Alzheimer's type. Arch Neurol. 1995 Jun;52(6):626-34. Abstract
90. Oppenheim G. The earliest signs of Alzheimer's disease. J Geriatr Psychiatry Neurol. 1994 Apr-Jun;7(2):116-20. Abstract
91. Cummings JL, Miller B, Hill MA, et al. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol. 1987 Apr;44(4):389-93. Abstract
92. Tampi RR, van Dyck CH, et al. Behavioral and psychological symptoms of Alzheimer's disease. In: Sun MK (ed). Research progress in Alzheimer's disease and dementia (Vol 2). Hauppauge, NY: Blanchette Rockefeller Neurosciences Institute, Nova Publishers; 2006:251-72.
93. Mathias JL, Morphett K. Neurobehavioral differences between Alzheimer's disease and frontotemporal dementia: a meta-analysis. J Clin Exp Neuropsychol. 2010 Aug;32(7):682-98. Abstract
94. Silva MT, Laks J, Engelhardt E. Neuropsychological tests and driving in dementia: a review of the recent literature. Rev Assoc Med Bras. 2009 Jul-Aug;55(4):484-8. Abstract
95. Ivnik RJ, Malec JF, Smith GE, et al. Mayo's older American normative studies. Clin Neuropsychol. 1992;6(Suppl):83-104.
96. Larson EB, Reifler BV, Sumi SM, Canfield CG, Chinn NM. Diagnostic tests in the evaluation of dementia: a prospective study of 200 elderly outpatients. Arch Intern Med. 1986 Oct;146(10):1917-22. Abstract
97. Centers for Disease Control and Prevention. Sexually transmitted infections treatment guideline, 2021: syphilis. Oct 2024 [internet publication].Full text
98. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May;7(3):263-9.Full text Abstract
99. Jack CR Jr, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association workgroup. Alzheimers Dement. 2024 Aug;20(8):5143-69.Full text Abstract
100. Kokkinou M, Beishon LC, Smailagic N, et al. Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting. Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD010945.Full text Abstract
101. Frisoni GB, Festari C, Massa F, et al. European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders. Lancet Neurol. 2024 Mar;23(3):302-12. Abstract
102. American College of Radiology. ACR appropriateness criteria: dementia. 2024 [internet publication].Full text
103. Filippi M, Agosta F, Barkhof F, et al. EFNS task force: the use of neuroimaging in the diagnosis of dementia. Eur J Neurol. 2012 Dec;19(12):e131-40, 1487-501.Full text Abstract
104. Dormont D, Seidenwurm DJ, Expert Panel on Neurologic Imaging, et al. Dementia and movement disorders. AJNR Am J Neuroradiol. 2008 Jan;29(1):204-6.Full text Abstract
105. Banerjee D, Muralidharan A, Hakim Mohammed AR, et al. Neuroimaging in dementia: a brief review. Cureus. 2020 Jun 18;12(6):e8682.Full text Abstract
106. Ismail Z, Black SE, Camicioli R, et al. Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Alzheimers Dement. 2020 Aug;16(8):1182-95.Full text Abstract
107. Yuan Y, Gu ZX, Wei WS. Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis. AJNR Am J Neuroradiol. 2009 Feb;30(2):404-10.Full text Abstract
108. Ducharme S, Dols A, Laforce R, et al. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Brain. 2020 Jun 1;143(6):1632-50.Full text Abstract
109. Boeve BF, Boxer AL, Kumfor F, et al. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. Lancet Neurol. 2022 Mar;21(3):258-72. Abstract
110. Tarnaris A, Kitchen ND, Watkins LD. Noninvasive biomarkers in normal pressure hydrocephalus: evidence for the role of neuroimaging. J Neurosurg. 2009 May;110(5):837-51. Abstract
111. Pennington C, Chohan G, Mackenzie J, et al. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease. Neurosci Lett. 2009 May 8;455(1):56-9. Abstract
112. Mitchell AJ, Meader N, Pentzek M. Clinical recognition of dementia and cognitive impairment in primary care: a meta-analysis of physician accuracy. Acta Psychiatr Scand. 2011 Sep;124(3):165-83. Abstract
113. Goldman JS, Hahn SE, Catania JW, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med. 2011 Jun;13(6):597-605.Full text Abstract
114. Brouwers N, Sleegers K, Van Broeckhoven C. Molecular genetics of Alzheimer's disease: an update. Ann Med. 2008;40(8):562-83.Full text Abstract
115. Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021 Jan;20(1):68-80.Full text Abstract
116. Burgunder JM, Finsterer J, Szolnoki Z, et al. EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias. Eur J Neurol. 2010 May;17(5):641-8.Full text Abstract
117. Montine TJ, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012 Jan;123(1):1-11.Full text Abstract
118. World Health Organization. ICD-11 for mortality and morbidity statistics. Jan 2025 [internet publication].Full text
119. Gosche KM, Mortimer JA, Smith CD, et al. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun study. Neurology. 2002 May 28;58(10):1476-82. Abstract
120. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997 Sep;49(3):786-94. Abstract
121. Scheltens P, Fox N, Barkhof F, et al. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol. 2002;1:13-21. Abstract
122. van der Flier WM, Scheltens P. Use of laboratory and imaging investigations in dementia. J Neurol Neurosurg Psychiatry. 2005 Dec;76(suppl 5):v45-52. Abstract
123. Meyer MA, Hudock SA. Posterior cortical atrophy: A rare variant of Alzheimer's disease. Neurol Int. 2018 May 24;10(2):7665.Full text Abstract
124. Liyanagedera S, Bracewell RM, Larner AJ. Diagnosing dementia with Lewy bodies: new diagnostic criteria. J R Coll Physicians Edinb. 2018 Mar;48(1):44-45.Full text Abstract
125. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017 Jul 4;89(1):88-100.Full text Abstract
126. Aarsland D, Kurz MW. The epidemiology of dementia associated with Parkinson disease. J Neurol Sci. 2010 Feb 15;289(1-2):18-22. Abstract
127. Bean L, Bayrak-Toydemir P. American College of Medical Genetics and Genomics Standards and Guidelines for Clinical Genetics Laboratories, 2014 edition: technical standards and guidelines for Huntington disease. Genet Med. 2014 Dec;16(12):e2.Full text Abstract
128. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008 May;93(5):1526-40.Full text Abstract
129. Yuen KCJ, Biller BMK, Radovick S, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract. 2019 Nov;25(11):1191-232.Full text Abstract
130. Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68. Abstract
131. Wang B, Bonkovsky HL, Lim JK, et al. AGA Clinical practice update on diagnosis and management of acute hepatic porphyrias: expert review. Gastroenterology. 2023 Mar;164(3):484-91.Full text Abstract
132. Thadani H, Deacon A, Peters T. Diagnosis and management of porphyria. BMJ. 2000 Jun 17;320(7250):1647-51.Full text Abstract
133. Korman JD, Volenberg I, Balko J, et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology. 2008 Oct;48(4):1167-74.Full text Abstract
134. Schilsky ML, Roberts EA, Bronstein JM, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 practice guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. 2022 Dec 7.Full text Abstract
135. European Association for Study of Liver. EASL clinical practice guidelines: Wilson's disease. J Hepatol. 2012 Mar;56(3):671-85.Full text Abstract
136. Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician. Arch Intern Med. 1999 Jun 28;159(12):1289-98. Abstract
137. Mead P, Petersen J, Hinckley A. Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):703.Full text Abstract
138. National Institute for Health and Care Excellence. Lyme disease. Oct 2018 [internet publication].Full text
139. Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017 Jan 15;64(2):111-5.Full text Abstract
140. Geldmacher H, Taube C, Kroeger C, et al. Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest. 2002 Apr;121(4):1177-82. Abstract
141. Weir MR, Thornton GF. Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature. Am J Med. 1985 Oct;79(4):467-78. Abstract
142. Baydur A. The spectrum of extrapulmonary tuberculosis. West J Med. 1977 Apr;126(4):253-62.Full text Abstract
143. Nataraj G, Kurup S, Pandit A, et al. Correlation of fine needle aspiration cytology, smear and culture in tuberculous lymphadenitis: a prospective study. J Postgrad Med. 2002 Apr-Jun;48(2):113-6.Full text Abstract
144. Muneer A, Macrae B, Krishnamoorthy S, et al. Urogenital tuberculosis - epidemiology, pathogenesis and clinical features. Nat Rev Urol. 2019 Oct;16(10):573-98. Abstract
145. World Health Organization. WHO consolidated guidelines on tuberculosis: module 3: diagnosis. Apr 2025 [internet publication].Full text
146. Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):7-10.Full text Abstract
147. Bjerrum S, Schiller I, Dendukuri N, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev. 2019 Oct 21;10(10):CD011420.Full text Abstract
148. Papp JR, Park IU, Fakile Y, et al. CDC laboratory recommendations for syphilis testing, United States, 2024. MMWR Recomm Rep 2024;73(No. RR-1):1-32.Full text
149. World Health Organization. WHO guidelines for the treatment of Treponema pallidum (syphilis). Jan 2016 [internet publication].Full text
150. World Health Organization. Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (syphilis) and new recommendations on syphilis testing and partner services. Jul 2024 [internet publication].Full text
151. Timmermans M, Carr J. Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1727-30.Full text Abstract
152. British Association for Sexual Health and HIV. Updated guideline: syphilis 2024. Sep 2024 [internet publication].Full text
153. Gordon C, Amissah-Arthur MB, Gayed M, et al. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology (Oxford). 2018 Jan 1;57(1):e1-45.Full text
154. Newman LS, Rose CS, Maier LA. Sarcoidosis [published correction appears in N Engl J Med. 1997;337:139]. N Engl J Med. 1997 Apr 24;336(17):1224-34. Abstract
155. Relkin N, Marmarou A, Klinge P, et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005 Sep;57(suppl 3):S4-16. Abstract
Use of this content is subject to our disclaimer